|
60
|
226
|
5l63H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
250
|
5l63A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
196
|
5l64N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
250
|
5l64A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
68
|
233
|
5l63M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
233
|
5l65M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
70
|
244
|
5l67B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
70
|
243
|
5l67F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
233
|
5l67M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
226
|
5l65H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
244
|
5l64B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
56
|
195
|
5l64J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
61
|
241
|
5l63G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
63
|
241
|
5l66G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
222
|
5l66L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
69
|
242
|
5l66D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
59
|
226
|
5l66H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
70
|
240
|
5l5eC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
250
|
5l5xA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
58
|
204
|
5l67I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
58
|
195
|
5l67J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
240
|
5l5wC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
64
|
231
|
5l5zE |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
69
|
244
|
5l5zB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
241
|
5l5vG |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
226
|
5l5vH |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
53
|
216
|
5m32M |
Human 26s proteasome in complex with oprozomib |
|
63
|
241
|
5l5zG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
222
|
5m2bL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
58
|
196
|
5m2bN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
59
|
196
|
5l5zN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
0
|
13
|
5m32r |
Human 26s proteasome in complex with oprozomib |
|
79
|
375
|
5m32m |
Human 26s proteasome in complex with oprozomib |
|
97
|
422
|
5m32l |
Human 26s proteasome in complex with oprozomib |
|
64
|
231
|
5m2bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
71
|
243
|
5l5vF |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
60
|
195
|
5l5sJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
233
|
5l5yM |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
61
|
222
|
5l5yL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
58
|
204
|
5l5yI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
233
|
5l5uM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
63
|
231
|
5l5vE |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
226
|
5l62H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
353
|
5m32c |
Human 26s proteasome in complex with oprozomib |
|
8
|
139
|
5m32p |
Human 26s proteasome in complex with oprozomib |
|
51
|
301
|
5m32i |
Human 26s proteasome in complex with oprozomib |
|
46
|
342
|
5m32d |
Human 26s proteasome in complex with oprozomib |
|
59
|
196
|
5l5wN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
40
|
238
|
5m32S |
Human 26s proteasome in complex with oprozomib |
|
62
|
231
|
5l60E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
